Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
64Cu/68Ga Labelled EB-ss-CPT PET/CT in Colorectal Cancer
NCT05891028Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- May 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of EB-ss-CPT in colorectal cancer (CRC), sponsored by Peking Union Medical College Hospital. Primary endpoints: Dosimetric distribution of radiopharmaceuticals at 2 months and Standardized uptake value at 1 year. Status: unknown.
02
Drugs
EB-ss-CPT
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05891028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05891028.